TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension

dc.contributor.authorSantiago Hernández, Aranzazu
dc.contributor.authorMartín Lorenzo, Marta
dc.contributor.authorMartín Blázquez, Ariadna
dc.contributor.authorRuiz Hurtado, Gema
dc.contributor.authorBarderas, María G.
dc.contributor.authorSegura, Julián
dc.contributor.authorRuilope Urioste, Luis Miguel
dc.contributor.authorÁlvarez Llamas, Gloria
dc.date.accessioned2021-09-21T13:03:42Z
dc.date.available2021-09-21T13:03:42Z
dc.date.issued2021
dc.description.abstractModerately increased albuminuria, defined by an albumin to creatinine ratio(ACR) > 30 mg/g,is an indicator of subclinical organ damage associated with a higher risk of cardiovascular and renal dis-ease. Normoalbuminuric subjects are considered at no cardiorenal risk in clinical practice, and molecularchanges underlying early development are unclear. To decipher subjacent mechanisms, we stratifiedthe normoalbuminuria condition. A total of 37 hypertensive patients under chronic renin–angiotensinsystem (RAS) suppression with ACR values in the normoalbuminuria range were included and classifiedas control (C) (ACR < 10 mg/g) and high-normal (HN) (ACR = 10–30 mg/g). Target metabolomicanalysis was carried out by liquid chromatography and mass spectrometry to investigate the role ofthe cardiorenal risk urinary metabolites previously identified. Besides this, urinary free fatty acids (FFAs),fatty acid binding protein 1 (FABP1) and nephrin were analyzed by colorimetric and ELISA assays.A Mann–Whitney test was applied, ROC curves were calculated and Spearman correlation analysis wascarried out. Nine metabolites showed significantly altered abundance in HN versus C, and urinary FFAsand FABP1 increased in HN group, pointing to dysregulation in the tricarboxylic acid cycle (TCA) cycleand fatty acidsβ-oxidation. We showed here how cardiorenal metabolites associate with albuminuria,already in the normoalbuminuric range, evidencing early renal damage at a tubular level and suggestingincreasedβ-oxidation to potentially counteract fatty acids overload in the HN range.spa
dc.description.filiationUEMspa
dc.description.impact7.675 JCR (2021) Q1, 50/297 Biochemistry & Molecular Biologyspa
dc.description.impact1.008 SJR (2021) Q1, 29/119 Clinical Biochemistryspa
dc.description.impactNo data IDR 2021spa
dc.description.sponsorshipInstituto de Salud Carlos III y FEDER subvenciones (PI16 / 01334, PI20 / 01103, PI17 / 01093, PI17 / 01193, IF08 / 3667-1, CPII15 / 00027, CP15 / 00129, CPII20 / 00022, PT13 / 0001/0013 y PRB3 [IPT17 / 0019-ISCIII-SGEFI / ERDF]); REDinREN (RD16 / 0009).spa
dc.description.sponsorshipFundación SENEFRO / SEN, CAM (PEJD-2019-PRE / BMD-16992, 2018-T2 / BMD-11561).spa
dc.identifier.citationSantiago Hernández, A., Martín Lorenzo, M., Martín Blázquez, A., Ruiz Hurtado, G., Barderas, M. G., Segura, J., Ruilope, L. M., & Álvarez Llamas, G. (2021). TCA cycle and fatty acids oxidation reflect early cardiorenal damage in normoalbuminuric subjects with controlled hypertension. Antioxidants, 10(7), 1100. https://doi.org/10.3390/antiox10071100spa
dc.identifier.doi10.3390/antiox10071100
dc.identifier.issn2076-3921
dc.identifier.urihttp://hdl.handle.net/11268/10365
dc.language.isoengspa
dc.peerreviewedSispa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionalspa
dc.rights.accessRightsopen accessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.otherHipertensiónspa
dc.subject.otherÁcidos grasosspa
dc.subject.otherSíndrome cardiorrenalspa
dc.subject.unescoEnfermedad cardiovascularspa
dc.titleTCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertensionspa
dc.typejournal articlespa
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ruilope_anti_2021.pdf
Size:
1.31 MB
Format:
Adobe Portable Document Format
Description:
Versión del editor